Kobayashi Pharmaceutical Co (KOY) Stock Statistics & Valuation Metrics

Kobayashi Pharmaceutical Co has a market cap or net worth of EUR 2.98B. The enterprise value is EUR 348.55B.

Market Cap

EUR 2.98B

Enterprise Value

EUR 348.55B

Kobayashi Pharmaceutical Co has 78,050,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

78,050,000

Owned by Insiders

―

Owned by Institutions

6.46%

Kobayashi Pharmaceutical Co’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 6.77%.

Return on Equity (ROE)

0.02

Return on Assets (ROA)

0.01

Return on Invested Capital (ROIC)

6.77%

Return on Capital Employed (ROCE)

0.07

Revenue Per Employee

44.42M

Profits Per Employee

979.90K

Employee Count

3,731

Asset Turnover

0.60

Inventory Turnover

3.56

The current PE Ratio of Kobayashi Pharmaceutical Co is 324.14. Kobayashi Pharmaceutical Co’s PEG ratio is -3.76.

PE Ratio

324.14

PS Ratio

3.15

PB Ratio

2.51

Price to FCF

0.00

Price to Operating Cash Flow

0.00

PEG Ratio

-3.76

In the last 12 months, Kobayashi Pharmaceutical Co had revenue of 165.74B and earned 3.66B in profits. Earnings per share was 49.18.

Revenue

165.74B

Gross Profit

84.71B

Operating Income

14.92B

Pretax Income

3.74B

Net Income

3.66B

EBITDA

12.52B

Earnings Per Share (EPS)

49.18

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow

0

Free Cash Flow

0

Free Cash Flow per Share

0.00

Kobayashi Pharmaceutical Co pays an annual dividend of ―, resulting in a dividend yield of 1.40%

Dividend Per Share

―

Dividend Yield

1.40%

Payout Ratio

N/A

Free Cash Flow Yield

0.00%

Earnings Yield

0.31%

Beta

0.24

52-Week Price Change

42.03%

50-Day Moving Average

34.93

200-Day Moving Average

30.84

Relative Strength Index (RSI)

60.17

Average Volume (3m)

16

Kobayashi Pharmaceutical Co upcoming earnings date is Nov 10, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 06, 2026

Next Earnings Date

Nov 10, 2026

Ex-Dividend Date

―

Kobayashi Pharmaceutical Co as a current ratio of 2.47, with Debt / Equity ratio of 0.32%

Current Ratio

2.47

Quick Ratio

2.10

Debt to Market Cap

0.00

Net Debt to EBITDA

-4.92

Interest Coverage Ratio

532.96

In the past 12 months, Kobayashi Pharmaceutical Co has paid 83.00M in taxes.

Income Tax

83.00M

Effective Tax Rate

0.02

Kobayashi Pharmaceutical Co EV to EBITDA ratio is 42.34, with an EV/FCF ratio of 0.00.

EV to Sales

2.85

EV to EBITDA

42.34

EV to Free Cash Flow

0.00

EV to Operating Cash Flow

0.00

Kobayashi Pharmaceutical Co has EUR 57.33B in cash and marketable securities with EUR 723.00M in debt, giving a net cash position of EUR 56.61B billion.

Cash & Marketable Securities

EUR 57.33B

Total Debt

EUR 723.00M

Net Cash

EUR 56.61B

Net Cash Per Share

EUR 725.25

Tangible Book Value Per Share

EUR 2,597.65

Gross margin is 50.26%, with operating margin of 6.23%, and net profit margin of 0.97%.

Gross Margin

50.26%

Operating Margin

6.23%

Pretax Margin

1.02%

Net Profit Margin

0.97%

EBITDA Margin

6.73%

EBIT Margin

1.23%

The average price target for Kobayashi Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-5.99%

EPS Growth Forecast

-86.56%